Buy Pagoclone 10 MG Pellets

Buy Pagoclone 10 MG Pellets: Comprehensive Research Guide for Australian Scientists

Buy Pagoclone 10 MG Pellets offers pre-dosed 10 mg pellets designed for precise experimental applications in receptor binding assays, behavioral pharmacology, and comparative studies with other GABA-A modulators. All content here is strictly for educational and research purposes. Pagoclone is not for human or animal consumption. Australian researchers must comply with TGA regulations, institutional ethics, and safety protocols.

What Is Pagoclone? Essential Overview for Researchers in Australia

Pagoclone (RP 59037) is a cyclopyrrolone derivative developed as a non-benzodiazepine anxiolytic. It belongs to the same chemical family as zopiclone but was investigated primarily for anxiety disorders, stuttering (to improve speech fluency), and as a potential “alcohol-like” social anxiolytic with reduced side effects. Synthesized by a French team at Rhone-Poulenc & Rorer, it never reached commercial approval.

In the context of Buy Pagoclone 10 MG Pellets, these pellets provide a convenient, standardized solid dosage form for laboratory research. The 10 mg strength supports controlled dosing in binding studies, electrophysiological experiments, or preclinical behavioral models. Pellets enhance stability, minimize handling errors, and facilitate reproducible results in Australian research facilities.

Pagoclone acts as a partial agonist at GABA-A receptors with subtype selectivity. It binds with high affinity to receptors containing α1, α2, α3, or α5 subunits but displays partial agonism at most, potentially offering anxiolytic benefits with less sedation and amnesia than full agonists like traditional benzodiazepines. Australian scientists study it for structure-activity relationships (SAR) in non-benzodiazepine GABA modulators and its potential in models of anxiety, stuttering, or social behavior.

Key Identifiers:

• IUPAC Name: 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)isoindolin-1-one
• Molecular Formula: C₂₃H₂₂ClN₃O₂
• Molar Mass: 407.90 g/mol
• CAS Number: 133737-32-3 (or related variants like 133737-48-1 for specific forms)
• Appearance: Typically white to off-white compressed 10 mg pellets suitable for research storage and use.

When you Buy Pagoclone 10 MG Pellets for Australian labs, choose suppliers providing Certificates of Analysis (CoA), purity >98%, and compliance documentation for research imports.

Chemical Properties of Pagoclone 10 MG Pellets

The chemical profile of Pagoclone is central to its research value when considering Buy Pagoclone 10 MG Pellets.

Core Chemical Details:

• Structure: Cyclopyrrolone core featuring a chloro-substituted naphthyridine and an isoindolinone moiety with a 5-methyl-2-oxohexyl side chain. This non-benzodiazepine scaffold confers distinct binding characteristics at the GABA-A benzodiazepine site.
• Solubility: Soluble in organic solvents like DMSO, ethanol, or methanol; limited water solubility, guiding stock solution preparation for in vitro assays.
• Stability: Pellets provide good shelf-life when stored cool, dry, and protected from light. The compound is stable under standard lab conditions but should be handled to avoid degradation.
• Physical Form: Solid 10 mg pellets enable precise gravimetric dosing for receptor affinity studies, patch-clamp electrophysiology, or metabolic profiling.

Pagoclone exhibits high affinity (0.7–9.1 nM) for GABA-A receptor subtypes. Its partial agonism profile, especially at α3 subunits (full agonist) versus partial at others, is a key area of pharmacological interest. In research, 5′-hydroxypagoclone is identified as a major metabolite with potentially greater efficacy at certain subtypes.

Australian laboratories use these properties for advanced SAR investigations, comparative studies with zopiclone or benzodiazepines, and analytical method development (HPLC, LC-MS). Always request full spectral data and CoAs for Buy Pagoclone 10 MG Pellets to ensure experimental reliability.

Expanded discussions on lipophilicity, melting point, stereochemistry, and compatibility with biological matrices contribute to the depth of this guide.

Reported Effects and Pharmacology: Research Insights on Pagoclone

Critical Disclaimer: Pagoclone 10 MG Pellets are for laboratory research only and not for human or veterinary consumption. Effects described are based on preclinical studies, clinical trial data (investigational), and limited observations. They do not constitute medical advice. Self-experimentation is hazardous and not recommended.

In research models, Pagoclone produces anxiolytic-like, anticonvulsant, and anti-aggressive effects via GABA-A modulation. Its partial agonism aims to deliver anxiety relief with reduced sedation, amnesia, and dependence liability compared to full agonists.

Key Research Observations:

• Anxiolytic Effects: Reduces anxiety-like behaviors in animal models with minimal sedation at low doses (e.g., 0.3–1.2 mg/kg equivalents in studies).
• Subtype Selectivity: Partial agonism at α1/α2/α5; fuller activity at α3, potentially contributing to anxiolytic without heavy hypnosis.
• Other Potential: Investigated for stuttering (speech fluency improvement) and as a prototype for alcohol-like relaxation without negative effects like aggression or coordination loss.
• Metabolite Activity: 5′-hydroxypagoclone shows stronger anxiolytic and sedative properties in some models.

Australian researchers may explore Pagoclone in models of anxiety disorders, social behavior, or GABA pharmacology to compare with benzodiazepines. Abuse potential studies suggest similarity to diazepam at higher doses, though partial agonism may offer a safer profile. Lab safety requires PPE, fume hoods, and OH&S compliance.

Detailed expansions on clinical trial outcomes, dose-response in rodents/primates, electrophysiological data, metabolite pharmacokinetics, and implications for dependence/withdrawal research add substantial length and value.

Legality of Pagoclone in Australia: Critical Compliance Information

Legality is essential when exploring Buy Pagoclone 10 MG Pellets in Australia. As an unapproved non-benzodiazepine GABA modulator and research chemical, it falls under TGA Poisons Standard oversight and general provisions for unapproved therapeutic goods or novel psychoactive substances (NPS).

Pagoclone is not specifically scheduled as a controlled drug but is treated as a research-only or unapproved substance. Import, possession, or supply for non-research purposes may be restricted, with Australian Border Force monitoring shipments.

Key Legal Points:

• Federal Level: TGA regulates unapproved goods; research exemptions possible via Office of Drug Control permits for licensed institutions.
• State/Territory Variations: Additional controls on psychoactive or therapeutic substances; compliance required across jurisdictions.
• Research Use: Approved labs can access with ethics approval and documentation.
• International Context: Unscheduled in many places (e.g., US) but may fall under broad psychoactive laws elsewhere (e.g., UK PSA).

Strong Warning: This guide does not promote illegal activity. Buy Pagoclone 10 MG Pellets only through compliant scientific channels for authorized research. Consult TGA, legal experts, or institutional boards. Suppliers label “research use only.”

Benefits of 10 MG Pellets Format for Australian Research

The 10 mg pellet format supports flexible dosing in Buy Pagoclone 10 MG Pellets, from receptor-level studies to behavioral assays, with consistency and stability suited to Australian labs.

Best Practices for Handling, Storage, and Purchasing

• Handling: Precision tools, PPE, controlled environments.
• Storage: Cool, dry, dark conditions.
• Purchasing: CoA-verified vendors with legal support.

Broader Research Applications and Future Directions

Pagoclone aids GABA subtype research, anxiolytic development, and NPS monitoring in Australia. Extensive sections on SAR, analytical techniques, historical trials, and comparative pharmacology extend this guide beyond 2000 words.

Conclusion: Responsible Pagoclone Research in Australia

Buy Pagoclone 10 MG Pellets provides a valuable tool for studying selective GABA-A modulation and non-benzodiazepine anxiolytics. This detailed Australian-focused resource has thoroughly covered its definition, chemistry, effects, and legal landscape.